Evidence map›Paper›PMID 34782683›Full record

ArticleScientific reports2021

Red blood cell transfusion induces abnormal HIF-1α response to cytokine storm after adult cardiac surgery.

Emma Viikinkoski, Juho Jalkanen, Jarmo Gunn, Tuija Vasankari, Joonas Lehto, Mika Valtonen, Fausto Biancari, Sirpa Jalkanen, K E Juhani Airaksinen, Maija Hollmén and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03444259 (Cardiovascular Research Consortium - a Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03444259 active not recruitingnot on this map

Cardiovascular Research Consortium - a Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients

Typeobservational_patient_registrySponsorUniversity of TurkuRan2016 to 2029Enrolled1,001ConditionsAtrial Fibrillation, Coronary Artery Disease, Aortic Valve Stenosis, Aortic Valve DiseaseArmsCardiac surgery
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Emma ViikinkoskiHeart Center, Turku University Hospital and University of Turku, Hämeenkatu 11, 20521, Turku, Finland.
Juho JalkanenMediCity Research Laboratory, Department of Microbiology and Immunology, University of Turku, Tykistönkatu 6A, 20520, Turku, Finland.
Jarmo GunnHeart Center, Turku University Hospital and University of Turku, Hämeenkatu 11, 20521, Turku, Finland.
Tuija VasankariHeart Center, Turku University Hospital and University of Turku, Hämeenkatu 11, 20521, Turku, Finland.
Joonas LehtoHeart Center, Turku University Hospital and University of Turku, Hämeenkatu 11, 20521, Turku, Finland.
Mika ValtonenIntensive Care Unit, Turku University Hospital and University of Turku, Hämeenkatu 11, 20521, Turku, Finland.
Fausto BiancariHeart Center, Turku University Hospital and University of Turku, Hämeenkatu 11, 20521, Turku, Finland.
Sirpa JalkanenMediCity Research Laboratory, Department of Microbiology and Immunology, University of Turku, Tykistönkatu 6A, 20520, Turku, Finland.
K E Juhani AiraksinenHeart Center, Turku University Hospital and University of Turku, Hämeenkatu 11, 20521, Turku, Finland.
Maija HollménMediCity Research Laboratory, Department of Microbiology and Immunology, University of Turku, Tykistönkatu 6A, 20520, Turku, Finland.
Tuomas O KiviniemiHeart Center, Turku University Hospital and University of Turku, Hämeenkatu 11, 20521, Turku, Finland. tuoski@utu.fi.
University of Turku · FITurku University Hospital · FIBrigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients undergoing cardiac surgery develop a marked postoperative systemic inflammatory response. Blood transfusion may contribute to disruption of homeostasis in these patients. We sought to evaluate the impact of blood transfusion on serum interleukin-6 (IL-6), hypoxia induced factor-1 alpha (HIF-1α) levels as well as adverse outcomes in patients undergoing adult cardiac surgery. We prospectively enrolled 282 patients undergoing adult cardiac surgery. Serum IL-6 and HIF-1α levels were measured preoperatively and on the first postoperative day. Packed red blood cells were transfused in 26.3% of patients (mean 2.93 ± 3.05 units) by the time of postoperative sampling. Postoperative IL-6 levels increased over 30-fold and were similar in both groups (p = 0.115), whilst HIF-1α levels (0.377 pg/mL vs. 0.784 pg/mL, p = 0.002) decreased significantly in patients who received red blood cell transfusion. Moreover, greater decrease in HIF-1α levels predicted worse in-hospital and 3mo adverse outcome. Red blood cell transfusion was associated with higher risk of major adverse outcomes (stroke, pneumonia, all-cause mortality) during the index hospitalization. Red blood cell transfusion induces blunting of postoperative HIF-1 α response and is associated with higher risk of adverse thrombotic and pulmonary adverse events after cardiac surgery. Clinical Trial Registration ClinicalTrials.gov Identifier: NCT03444259.

Indexed as

Cardiac Surgical ProceduresPostoperative ComplicationsAgedAged, 80 and overBiomarkersCritical CareCytokine Release SyndromeCytokinesDisease SusceptibilityErythrocyte TransfusionFemaleHospitalizationHumansHypoxia-Inducible Factor 1, alpha SubunitMalePatient Outcome AssessmentBiomarkersCytokinesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha Subunit

Identifiers

PMID34782683
PMCPMC8592994
OpenAlexW3212711183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.